About Walter Klemp
Walter Klemp is a director at Autonomix Medical.
Walter Klemp reports to the SEC as a director, officer or major shareholder of 3 public companies, including Moleculin Biotech (MBRX) and Soliton (SOLY).
Walter Klemp first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Walter Klemp in the role, so the role may have started earlier or lasted longer.
MI
Moleculin Biotech, Inc.
CEO and President, director
2016 – 2026 · Public company (MBRX)
SI
Soliton, Inc.
Executive Chairman
2019 – 2021 · Public company (SOLY)
Key Colleagues at Startups
The people Walter Klemp works with at each company, as listed on that company's latest Form D.
Autonomix Medical, Inc. · Form D, Jun 1, 2023
JF
Jonathan Foster
Director
DR
David Robins
Director
ML
Matthew Lourie
Chief Financial Officer
RS
Robert Schwartz
Executive officer